<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">scbmt-276</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>НОВЫЕ БИОМЕДИЦИНСКИЕ ТЕХНОЛОГИИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NEW BIOMEDICAL TECHNOLOGIES</subject></subj-group></article-categories><title-group><article-title>Сравнительное исследование токсических свойств комплекса оксованадия и его металлохелатного лиганда</article-title><trans-title-group xml:lang="en"><trans-title>A comparative study of toxicological properties of a oxovanadium (IV) complex and his metallohelat ligand</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>Н. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorobyeva</surname><given-names>N. M.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Федорова</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fedorova</surname><given-names>E. V.</given-names></name></name-alternatives><email xlink:type="simple">elena.fedorova@pharminnotech.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бурякина</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Buryakina</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вишневская</surname><given-names>Е. К.</given-names></name><name name-style="western" xml:lang="en"><surname>Vishnevskaya</surname><given-names>E. K.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Горбачева</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Gorbacheva</surname><given-names>T. V.</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аладышкина</surname><given-names>А. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>A.e</surname></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>ГОУ ВПО Санкт-Петербургская химико-фармацевтическая академия</institution><country>Russian Federation</country></aff><aff xml:lang="ru" id="aff-2"><institution>Бюро судебно-медицинской экспертизы, Санкт-Петербург</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2013</year></pub-date><pub-date pub-type="epub"><day>20</day><month>01</month><year>2020</year></pub-date><volume>1</volume><issue>4</issue><fpage>6</fpage><lpage>15</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воробьева Н.М., Федорова Е.В., Бурякина А.В., Вишневская Е.К., Горбачева Т.В., Аладышкина А.Е., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Воробьева Н.М., Федорова Е.В., Бурякина А.В., Вишневская Е.К., Горбачева Т.В., Аладышкина А.Е.</copyright-holder><copyright-holder xml:lang="en">Vorobyeva N.M., Fedorova E.V., Buryakina A.V., Vishnevskaya E.K., Gorbacheva T.V., Аладышкина А.Е.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/276">https://journal.scbmt.ru/jour/article/view/276</self-uri><abstract><p>Цель работы состояла в сравнительном изучении острой токсичности, кумулятивной активности нового органического комплекса оксованадия бис{трет-бутил[амино(имино)метил] карбамато}оксидованадия (IV) (БАМК) и его лиганда трет-бутоксикарбонилгуанидином (БКГ) и оценке их влияния на морфологию внутренних органов по сравнению с ванадил сульфатом. Величина ЛД50 для БАМК составила 178 мг/кг, для БКГ – 1003 мг/кг и для ванадил сульфата – 407 мг/кг. Согласно градации Hodge и Sterner БАМК и БКГ можно отнести к веществам с умеренной токсичностью, а БКГ – к малотоксичным соединениям. В результате исследования кумуляции было показано, что БАМК и ванадил сульфат обладают высокой кумулятивной активностью, а БКГ не кумулирует в органах животных.</p></abstract><trans-abstract xml:lang="en"><p>Aladyshkina The purpose of the work has consisted in comparative studying acute toxicity, cumulative activity of a new organic oxovanadium (IV) complex bis{tret-butyl[amino(imino)methyl]carbamato}oxydovanadium (IV) (BAMK) and his ligand tret-butoxycarbonylguanidine (BKG) and to the estimation of their influence on morphology of internals in comparison with vanadyl sulfate. Values of LD50 for the BAMK, BKG and vanadyl sulfate has averaged 178 mg / kg, 1003 mg / kg and 407 mg / kg correspondingly. According to the scale of Hodge and Sterner it is possible to attribute BAMK and BKG as the compounds with moderately toxic substances, and BKG – as compound with low toxicity. Because of research cumulation activity it has been shown, those БАМК and vanadyl sulfate have high cumulative activity, and BKG does not cumulate in internals of animals.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>средняя полулетальная доза</kwd><kwd>коэффициент кумуляции</kwd><kwd>ванадил сульфат</kwd><kwd>medium lethal dose</kwd><kwd>rate of cumulation</kwd><kwd>vanadyl sulfate</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Волкова О.В., Елецкий Ю.К. Основы гистологии с гистологической техникой. М.: Медицина. 1971. 271 с.</mixed-citation><mixed-citation xml:lang="en">Волкова О.В., Елецкий Ю.К. Основы гистологии с гистологической техникой. М.: Медицина. 1971. 271 с.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева Н.М., Федорова Е.В., Шкляренко А.А. Сравнительное исследование биологической активности комплекса оксованадия и его лиганда // В кн.: материалы 67-й открытой школы-конференции молодых ученых и студентов с международным участием "Актуальные вопросы экспериментальной и клинической медицины". Волгоград. 2009. 202 с.</mixed-citation><mixed-citation xml:lang="en">Воробьева Н.М., Федорова Е.В., Шкляренко А.А. Сравнительное исследование биологической активности комплекса оксованадия и его лиганда // В кн.: материалы 67-й открытой школы-конференции молодых ученых и студентов с международным участием "Актуальные вопросы экспериментальной и клинической медицины". Волгоград. 2009. 202 с.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Назаров Г.Н., Макаренко Т.Ф. Методы спектрального анализа в судебной медицине. – М.: МНПП «ЭСИ». 1994. 360 с.</mixed-citation><mixed-citation xml:lang="en">Назаров Г.Н., Макаренко Т.Ф. Методы спектрального анализа в судебной медицине. – М.: МНПП «ЭСИ». 1994. 360 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Прозоровский В.Б., Прозоровская М.П., Демченко В.М. Экспресс-метод определения средней эффективной дозы и ее ошибки // Фармакол. и Токсикол. 1978. №4. С. 497-502.</mixed-citation><mixed-citation xml:lang="en">Прозоровский В.Б., Прозоровская М.П., Демченко В.М. Экспресс-метод определения средней эффективной дозы и ее ошибки // Фармакол. и Токсикол. 1978. №4. С. 497-502.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Badmaev V., Prakash S., Majeed M.A. Vanadium. Review of its Potential Role in the Fight Against Diabetes // The Journal of Alternative and Complementary Medicine. 1999. Т. 5. С. 273-291.</mixed-citation><mixed-citation xml:lang="en">Badmaev V., Prakash S., Majeed M.A. Vanadium. Review of its Potential Role in the Fight Against Diabetes // The Journal of Alternative and Complementary Medicine. 1999. Т. 5. С. 273-291.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Barceloux D.G. Vanadium. // Clinical Toxicology. 1999. Т.37. № 2. С. 265-278.</mixed-citation><mixed-citation xml:lang="en">Barceloux D.G. Vanadium. // Clinical Toxicology. 1999. Т.37. № 2. С. 265-278.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dai S., Thompson K.H., Vera E., McNeill J.H. Toxicity studies on oneyear treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate // Pharmacol. and Toxicol. 1994. Т. 75. С. 265-273.</mixed-citation><mixed-citation xml:lang="en">Dai S., Thompson K.H., Vera E., McNeill J.H. Toxicity studies on oneyear treatment of non-diabetic and streptozotocin-diabetic rats with vanadyl sulphate // Pharmacol. and Toxicol. 1994. Т. 75. С. 265-273.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Dimond et al., Vanadium. Excretion, toxicity, lipid effect in man // Am. J. Clin. Nutr. 1963. Т. 12. С. 49-53.</mixed-citation><mixed-citation xml:lang="en">Dimond et al., Vanadium. Excretion, toxicity, lipid effect in man // Am. J. Clin. Nutr. 1963. Т. 12. С. 49-53.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Edel J., Sabbioni E. Vanadium transport across placenta and milk of rats to the foetus and newborn // Biological Trace Element Research. 1989. Т. 22. С. 265-275.</mixed-citation><mixed-citation xml:lang="en">Edel J., Sabbioni E. Vanadium transport across placenta and milk of rats to the foetus and newborn // Biological Trace Element Research. 1989. Т. 22. С. 265-275.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hodge H. C., Sterner J. H. Tabulation of toxicity classes // Am. Ind. Hyg. Assoc. J., 1949. Т. 10. С. 93-96.</mixed-citation><mixed-citation xml:lang="en">Hodge H. C., Sterner J. H. Tabulation of toxicity classes // Am. Ind. Hyg. Assoc. J., 1949. Т. 10. С. 93-96.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">http://shp.by.ru/health/bad/altera/ products.</mixed-citation><mixed-citation xml:lang="en">http://shp.by.ru/health/bad/altera/ products.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Lim R. K., Rink G., Glass H. G., Soaje-Echague E. A method of the evaluation of cumulation and tolerance by the determination of acute and sub chronic median effective dose. // Arch. Int. Pharmacodyn. 1961. Т. CXXX. № 3-4. С. 336-353.</mixed-citation><mixed-citation xml:lang="en">Lim R. K., Rink G., Glass H. G., Soaje-Echague E. A method of the evaluation of cumulation and tolerance by the determination of acute and sub chronic median effective dose. // Arch. Int. Pharmacodyn. 1961. Т. CXXX. № 3-4. С. 336-353.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Poucheret P., Verma S., Grynpas M.D., McNeill J.H. Vanadium and diabetes // Molecular and Cellular Biochemistry. 1998. Т. 188. С. 73-80.</mixed-citation><mixed-citation xml:lang="en">Poucheret P., Verma S., Grynpas M.D., McNeill J.H. Vanadium and diabetes // Molecular and Cellular Biochemistry. 1998. Т. 188. С. 73-80.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Rehder D. In vitro study of the insulinmimetic behaviour of vanadium (IV, V) coordination compounds // J. Biol. Inorg. Chem. 2002. Т. 7. С. 384-96.</mixed-citation><mixed-citation xml:lang="en">Rehder D. In vitro study of the insulinmimetic behaviour of vanadium (IV, V) coordination compounds // J. Biol. Inorg. Chem. 2002. Т. 7. С. 384-96.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Srivastava A. Anti-diabetic and toxic effects of vanadium compounds // Molecular and Cellular Biochemistry. 2000. Т. 206. С. 177-182.</mixed-citation><mixed-citation xml:lang="en">Srivastava A. Anti-diabetic and toxic effects of vanadium compounds // Molecular and Cellular Biochemistry. 2000. Т. 206. С. 177-182.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">http://www.patents.com/us-6245808. html.</mixed-citation><mixed-citation xml:lang="en">http://www.patents.com/us-6245808. html.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Zaporowska H., Wasilewski W. Some selected peripheral blood and haemopoietic system indices in Wistar rats with chronic vanadium intoxication // Can. J. Physiol. Pharmacol. 1989. Т. 75. № 2. С. 83-90.</mixed-citation><mixed-citation xml:lang="en">Zaporowska H., Wasilewski W. Some selected peripheral blood and haemopoietic system indices in Wistar rats with chronic vanadium intoxication // Can. J. Physiol. Pharmacol. 1989. Т. 75. № 2. С. 83-90.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Y., et al. The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes // J. Inorg. Biochem. 2006.Т. 100. с. 80.</mixed-citation><mixed-citation xml:lang="en">Zhang Y., et al. The permeability and cytotoxicity of insulin-mimetic vanadium (III,IV,V)-dipicolinate complexes // J. Inorg. Biochem. 2006.Т. 100. с. 80.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
